Showing results (641-650 of 746) with videos related to

Sort By:
Pageof 75
Eclinicalmedicine|August 21, 2023
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 studyPier Luigi Zinzani, Marek Trněný, Vincent Ribrag, et al.
Brain, Behavior, and Immunity|July 12, 2023
Insights into FcγR involvement in pain-like behavior induced by an RA-derived anti-modified protein autoantibodyAlexandra Jurczak, Katalin Sandor, Alex Bersellini Farinotti, et al.
Haematologica|August 19, 2021
Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphomaJohannes Duell, Kami J. Maddocks, Eva González-Barca, et al.
Clinical Science (London, England : 1979)|June 11, 2026
Adropin protects against cardiac remodeling and metabolic dysfunction in a male mouse HFpEF modelBellina A S Mushala, Michael W Stoner, Maryam Sharifi-Sanjani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell LymphomaMichael Wang, David Salek, David Belada, et al.
Pain|January 27, 2022
Lysophosphatidylcholine 16:0 mediates chronic joint pain associated to rheumatic diseases through acid-sensing ion channel 3Florian Jacquot, Spiro Khoury, Bonnie Labrum, et al.
Haematologica|July 1, 2021
Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphomaJohannes Duell, Kami J Maddocks, Eva González-Barca, et al.
Cardiovascular Research|June 15, 2022
Myocardial brain-derived neurotrophic factor regulates cardiac bioenergetics through the transcription factor Yin Yang 1Xue Yang, Manling Zhang, Bingxian Xie, et al.
Nature Immunology|February 19, 2020
Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysisFlorian J Weisel, Steven J Mullett, Rebecca A Elsner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patientsJ Czyz, R Dziadziuszko, W Knopinska-Postuszuy, et al.
Pageof 75